Xilio Therapeutics, Inc. (XLO) SEC filings
XLO SEC filings moved a median of -0.33% by the close. XLO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the XLO overview →
84 measured XLO SEC filing events.
Where these XLO SEC filings landedvs 82 measured XLO SEC filing reactions
| Middle 50% of XLO SEC filing reactions | -3.69% to +2.00% |
|---|---|
| Median reaction (to close) | -0.33% |
| Measured reactions | 82 |
Point-in-time · zero look-ahead
Half of the 82 XLO SEC filing events with a measured close landed between -3.69% and +2.00%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Xilio Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.42% | |
| Form 8-K Xilio Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +0.00% | -1.42% | |
| Form S-8 Xilio Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | -1.42% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jun 10 | SEC filing · Form 8-K | +1.09% | +0.97% | |
| Form EFFECT Xilio Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -2.60% | |
| Form S-3/A Xilio Therapeutics, Inc. | SEC filing · Form S-3 | +0.00% | +1.67% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.39% | +0.00% | |
| Form 8-K Xilio Therapeutics, Inc. For: May 12 | SEC filing · Form 8-K | -0.39% | +0.00% | |
| Form S-3 Xilio Therapeutics, Inc. | SEC filing · Form S-3 | -0.39% | +0.00% | |
| Form ARS Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +3.82% | -0.89% | |
| Form DEF 14A Xilio Therapeutics, Inc. For: Jun 10 | SEC filing · Form DEF | +3.82% | -0.89% | |
| Form 8-K Xilio Therapeutics, Inc. For: Apr 15 | SEC filing · Form 8-K | +7.13% | +1.95% | |
| Form 10-K Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.00% | -1.63% | |
| Form 8-K Xilio Therapeutics, Inc. For: Mar 23 | SEC filing · Form 8-K | -3.00% | -1.63% | |
| Form S-8 Xilio Therapeutics, Inc. | SEC filing · Form S-8 | -3.00% | -1.63% | |
| Form 8-K Xilio Therapeutics, Inc. For: Mar 12 | SEC filing · Form 8-K | -2.96% | +0.26% | |
| Form 8-K Xilio Therapeutics, Inc. For: Mar 09 | SEC filing · Form 8-K | +2.97% | +0.19% | |
| Form 8-K Xilio Therapeutics, Inc. For: Feb 23 | SEC filing · Form 8-K | +0.37% | +2.11% | |
| Form 8-K Xilio Therapeutics, Inc. For: Feb 11 | SEC filing · Form 8-K | +0.03% | +0.07% | |
| Form DEF 14A Xilio Therapeutics, Inc. For: Feb 23 | SEC filing · Form DEF | -0.63% | -0.61% | |
| Form PRE 14A Xilio Therapeutics, Inc. For: Jan 16 | SEC filing · Form PRE | -1.22% | -1.06% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jan 06 | SEC filing · Form 8-K | -0.55% | +1.33% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jan 05 | SEC filing · Form 8-K | +0.00% | -0.03% | |
| Form 8-K Xilio Therapeutics, Inc. For: Nov 21 | SEC filing · Form 8-K | -0.46% | -1.08% | |
| Form S-8 Xilio Therapeutics, Inc. | SEC filing · Form S-8 | -0.46% | -1.08% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.67% | — | |
| Form 8-K Xilio Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | -0.67% | — | |
| Form 8-K Xilio Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | -3.49% | -5.06% | |
| Form DEF 14A Xilio Therapeutics, Inc. For: Nov 21 | SEC filing · Form DEF | +0.64% | -3.37% | |
| Form PRE 14A Xilio Therapeutics, Inc. For: Nov 21 | SEC filing · Form PRE | +2.66% | -2.79% | |
| Form 8-K Xilio Therapeutics, Inc. For: Oct 02 | SEC filing · Form 8-K | +0.09% | +2.02% | |
| Form 8-K Xilio Therapeutics, Inc. For: Sep 09 | SEC filing · Form 8-K | +6.34% | +1.90% | |
| Form 8-K Xilio Therapeutics, Inc. For: Aug 22 | SEC filing · Form 8-K | +0.12% | +2.47% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.79% | -0.34% | |
| Form 8-K Xilio Therapeutics, Inc. For: Aug 14 | SEC filing · Form 8-K | -4.79% | -0.34% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jun 10 | SEC filing · Form 8-K | -0.47% | -3.55% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jun 10 | SEC filing · Form 8-K | +1.11% | +0.10% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jun 02 | SEC filing · Form 8-K | +0.40% | -3.73% | |
| Form DEFA14A Xilio Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.40% | -3.73% | |
| Form 8-K Xilio Therapeutics, Inc. For: May 31 | SEC filing · Form 8-K | -5.32% | -6.65% | |
| Form EFFECT Xilio Therapeutics, Inc. | SEC filing · Form EFFECT | -1.41% | +0.00% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.41% | +0.00% | |
| Form 8-K Xilio Therapeutics, Inc. For: May 08 | SEC filing · Form 8-K | +4.23% | +8.74% | |
| Form S-3/A Xilio Therapeutics, Inc. | SEC filing · Form S-3 | +2.13% | -2.34% | |
| Form ARS Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +1.38% | -4.32% | |
| Form DEF 14A Xilio Therapeutics, Inc. For: Jun 10 | SEC filing · Form DEF | +1.38% | -4.32% | |
| Form DEFA14A Xilio Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.38% | -4.32% | |
| Form PRE 14A Xilio Therapeutics, Inc. For: Jun 10 | SEC filing · Form PRE | -0.03% | +10.85% | |
| Form 8-K Xilio Therapeutics, Inc. For: Apr 04 | SEC filing · Form 8-K | +0.02% | +6.25% | |
| Form 10-K Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -4.79% | -4.52% | |
| Form 8-K Xilio Therapeutics, Inc. For: Mar 11 | SEC filing · Form 8-K | -4.79% | -4.52% | |
| Form S-3 Xilio Therapeutics, Inc. | SEC filing · Form S-3 | -4.76% | -5.66% | |
| Form S-8 Xilio Therapeutics, Inc. | SEC filing · Form S-8 | -4.79% | -4.52% | |
| Form 8-K Xilio Therapeutics, Inc. For: Feb 10 | SEC filing · Form 8-K | +6.54% | +8.82% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jan 21 | SEC filing · Form 8-K | +4.17% | -7.28% | |
| Form 8-K Xilio Therapeutics, Inc. For: Dec 18 | SEC filing · Form 8-K | -4.43% | -0.99% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -25.20% | -18.11% | |
| Form 8-K Xilio Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | -25.20% | -18.11% | |
| Form 8-K Xilio Therapeutics, Inc. For: Sep 10 | SEC filing · Form 8-K | +6.86% | +2.19% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.40% | +1.63% | |
| Form 8-K Xilio Therapeutics, Inc. For: Aug 08 | SEC filing · Form 8-K | +2.40% | +1.63% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | -1.04% | -0.33% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.77% | +2.83% | |
| Form 8-K Xilio Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | +3.77% | +2.83% | |
| Form EFFECT Xilio Therapeutics, Inc. | SEC filing · Form EFFECT | +1.59% | +0.00% | |
| Form S-3 Xilio Therapeutics, Inc. | SEC filing · Form S-3 | +3.96% | +6.93% | |
| Form ARS Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +2.88% | +4.81% | |
| Form DEF 14A Xilio Therapeutics, Inc. For: Jun 13 | SEC filing · Form DEF | +2.88% | +4.81% | |
| Form DEFA14A Xilio Therapeutics, Inc. | SEC filing · Form DEFA14A | +2.88% | +4.81% | |
| Form 10-K Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +4.22% | |
| Form 8-K Xilio Therapeutics, Inc. For: Apr 01 | SEC filing · Form 8-K | +0.00% | +4.22% | |
| Form S-8 Xilio Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | +4.22% | |
| Form 8-K Xilio Therapeutics, Inc. For: Mar 27 | SEC filing · Form 8-K | -10.94% | -43.75% | |
| Form 8-K Xilio Therapeutics, Inc. For: Mar 28 | SEC filing · Form 8-K | -5.30% | +15.91% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jan 19 | SEC filing · Form 8-K | +3.98% | +2.25% | |
| Form 8-K Xilio Therapeutics, Inc. For: Jan 01 | SEC filing · Form 8-K | -1.86% | +2.07% | |
| Form 8-K Xilio Therapeutics, Inc. For: Dec 07 | SEC filing · Form 8-K | +8.89% | +8.89% | |
| Form 10-K/A Xilio Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -10.63% | |
| Form 10-Q Xilio Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -10.63% | |
| Form 10-Q/A Xilio Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -10.63% | |
| Form 10-Q/A Xilio Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -10.63% | |
| Form 8-K Xilio Therapeutics, Inc. For: Nov 09 | SEC filing · Form 8-K | — | -10.63% | |
| Form 8-K Xilio Therapeutics, Inc. For: Nov 03 | SEC filing · Form 8-K | +0.15% | -12.20% |
Keep exploring
More XLO: earnings → · analyst actions → · XLO overview →